ArticleWorld journal of urology2025
Patients' understanding and perception of erectile dysfunction: Hong Kong versus Europe.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo estimate the prevalence of Erectile dysfunction (ED) in a Hong Kong (HK) population, evaluate the understanding and perception of ED and compare results with the European Association of Urology (EAU) and The Urology Foundation Trust (TRTed-TUF) data.
methodsA survey-based study was conducted between Dec 2023 and Mar 2024. The EAU and TRTed-TUF surveys were used as a template to design the current survey to ensure consistent reporting. Questions on the understanding of ED, healthcare seeking behaviour and awareness of treatment options were included. The survey was distributed via an online link to students and staff from The Hong Kong University (HKU) and to patients attending outpatient clinics at HKU Queen Mary Hospital.
results616 responses were received from men aged 18-81 years. The prevalence of ED in our population was 51.8%. 53.2% (EAU 33.6%) were incorrect about what ED is, 54.0% (EAU 56.5%) knew that ED could be treated and 26.4% (TRTed-TUF 22%) were aware that ED could be a sign of heart disease. 73.6% (EAU, 26.3%) do not talk with anyone about ED. 88.3% (TRTed-TUF 77%) would be more likely to seek help if they knew ED was a sign of heart disease. Up to 32.6% (EAU 17.2%) have heard of alternative therapies to oral phosphodiesterase-5 inhibitors.
conclusionsED awareness is low, and it is important to raise awareness possibly through charity campaigns, social media and education in primary care in order to detect underlying cardiovascular disease and reduce the impact of ED on psychosocial health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.